Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ELTX

Elicio Therapeutics (ELTX)

Elicio Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ELTX
DateTimeSourceHeadlineSymbolCompany
08/01/202508:30Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ELTXElicio Therapeutics Inc
19/12/202408:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELTXElicio Therapeutics Inc
12/12/202423:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELTXElicio Therapeutics Inc
12/12/202423:00GlobeNewswire Inc.Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024NASDAQ:ELTXElicio Therapeutics Inc
03/12/202423:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELTXElicio Therapeutics Inc
03/12/202423:00GlobeNewswire Inc.Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study EnrollmentNASDAQ:ELTXElicio Therapeutics Inc
25/11/202423:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELTXElicio Therapeutics Inc
25/11/202423:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELTXElicio Therapeutics Inc
23/11/202400:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ELTXElicio Therapeutics Inc
22/11/202408:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELTXElicio Therapeutics Inc
21/11/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ELTXElicio Therapeutics Inc
14/11/202408:21Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ELTXElicio Therapeutics Inc
14/11/202408:05GlobeNewswire Inc.Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:ELTXElicio Therapeutics Inc
08/11/202408:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELTXElicio Therapeutics Inc
08/11/202408:05GlobeNewswire Inc.Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual MeetingNASDAQ:ELTXElicio Therapeutics Inc
08/11/202401:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELTXElicio Therapeutics Inc
31/10/202423:30GlobeNewswire Inc.Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation SummitNASDAQ:ELTXElicio Therapeutics Inc
17/10/202423:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELTXElicio Therapeutics Inc
16/10/202423:30GlobeNewswire Inc.Elicio Therapeutics Reports Inducement GrantsNASDAQ:ELTXElicio Therapeutics Inc
03/10/202406:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELTXElicio Therapeutics Inc
03/10/202406:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELTXElicio Therapeutics Inc
03/10/202406:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELTXElicio Therapeutics Inc
28/09/202406:42Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ELTXElicio Therapeutics Inc
28/09/202406:41Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ELTXElicio Therapeutics Inc
18/09/202406:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ELTXElicio Therapeutics Inc
17/09/202422:31GlobeNewswire Inc.Elicio Therapeutics Reports Inducement GrantsNASDAQ:ELTXElicio Therapeutics Inc
13/09/202422:30GlobeNewswire Inc.Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile VaccinesNASDAQ:ELTXElicio Therapeutics Inc
28/08/202422:00GlobeNewswire Inc.Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ELTXElicio Therapeutics Inc
14/08/202406:30GlobeNewswire Inc.Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:ELTXElicio Therapeutics Inc
13/08/202406:05GlobeNewswire Inc.Elicio Therapeutics Announces Closing of Private Placement of $20.0 Million Convertible NoteNASDAQ:ELTXElicio Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ELTX

Your Recent History

Delayed Upgrade Clock